QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

ICUI

QT71ICU Medical, Inc.
NASDAQ·Healthcare·Medical - Instruments & Supplies·USA
Latest market price
140.37
+2.43+1.76%
OverviewShort InterestFilings
ICUIQT71ICU Medical, Inc.·NASDAQ
OverviewShort InterestFilings
140.37+1.76%
TA
Loading chart...
Screen all →
BDX+1.67%$143.98ALC+0.84%$64.68MDLN-1.32%$35.94WST+1.35%$327.95COO+1.32%$65.91BAX+2.58%$19.89ATR+0.28%$120.32RGEN-1.15%$132.02
Snapshot
Index-P/E73.71EPS (ttm)1.85
Insider Own18.86%
Shs Outstand24.99M
Perf Week-1.74%
Market Cap3.45BForward P/E15.14EPS next Y9.27Insider Trans3.13%Shs Float-Perf Month13.51%
Enterprise Value4.50BPEG0.00EPS next Q1.91Inst Own-Short Float-Perf Quarter10.85%
Income46.89MP/S1.60EPS this Y340.93%Inst Trans-Short Ratio-Perf Half Y-4.56%
Sales2.16BP/B1.62EPS next Y13.63%ROA1.15%Short Interest-Perf YTD-1.61%
Book/sh84.51P/C20.40EPS next 5Y7.98%ROE2.19%52W High160.29 -12.43%Perf Year8.00%
Cash/sh11.52P/FCF42.88EPS past 3/5Y-ROIC2.27%52W Low107.00 31.19%Perf 3Y-
Dividend Est.-EV/EBITDA17.13Sales past 3/5Y-0.74% 11.90%Gross Margin36.36%Volatility2.19% 2.50%Perf 5Y-
Dividend TTM-EV/Sales2.09EPS Y/Y TTM265.84%Oper. Margin3.72%ATR (14)4.84Perf 10Y-
Dividend Ex-Date-Quick Ratio1.13Sales Y/Y TTM-9.49%Profit Margin2.15%RSI (14)58.52Recom2.00
Dividend Gr. 3/5Y-Current Ratio2.30EPS Q/Q14.53%SMA202.27%Beta1.10Target Price165.50
Payout0.00%Debt/Eq0.64Sales Q/Q-12.40%SMA508.62%Rel Volume1.76Prev Close137.94
Employees15,000LT Debt/Eq0.64EarningsAug 06SMA2004.06%Avg Volume287.80KPrice140.37
IPO DateMar 31, 1992Option/ShortYes / YesEPS/Sales Surpr.10.67% 0.96%Net Debt/EBITDA4.01Volume506,718Change1.76%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-15-26InitiatedBTIGBuy$170
May-27-26UpgradeNeedhamHold → Buy$165
Apr-27-26ReiteratedKeybancOverweight$180 → $164
Apr-17-26ReiteratedPiper SandlerOverweight$178 → $163
Feb-20-26ReiteratedKeybancOverweight$173 → $180
Feb-20-26ReiteratedPiper SandlerOverweight$153 → $178
Oct-21-25ReiteratedKeybancOverweight$198 → $173
Sep-10-25ReiteratedPiper SandlerOverweight$145 → $153
Aug-15-25InitiatedPiper SandlerOverweight$145
Mar-12-25ReiteratedRaymond JamesOutperform$135 → $97
Latest News
Jun-15-26
Jun-15-2609:15AM
This ICU Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For MondayBenzinga
05:36AM
BTIG Initiates Coverage On ICU Medical with Buy Rating, Announces Price Target of $170Benzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue2,1562,2302,382
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A1,3721,4101,557
Gross Profit784820825
Selling, General and Administrative Excl. Other623625639
Research and Development858789
Other Operating Expense-5154
Operating Income8110743
Interest Expense88105107
Unusual Expense
———
Non-Operating Income (Expense)23-22
Net Income Before Taxes103-66
Income Taxes-38252
Consolidated Net Income461-118
Net Income From Continuing Operations461-118
Net Income461-118
EPS (Recurring)1.870.03-4.83
EPS (Basic, Before Extraordinaries)1.870.03-4.83
EPS (Diluted)1.850.03-4.83
EBITDA26332743
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio75.884,852.72—
Price To Sales Ratio1.631.60—
Gross Margin36.3636.7734.63
Operating Margin3.764.801.81
Net Margin2.130.04-4.95
Shares Outstanding252524
Market Capitalization3,5093,567—
Operating Lease Expense
———
Insider Trading Volume
$149.63$137.71$125.78$113.86$101.94● Close Price0.00M0.66M1.31M1.97M2.63MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Woolson DanielPresidentMay 22 '26Sale132.212,123280,68522,479May 22 12:00 AM
Sanzone Virginia RuthVP, General CounselMay 14 '26Sale124.082,447303,62419,460May 15 12:00 AM
FINNEY ELISHA WDirectorMay 13 '26Option Exercise0.002,50805,249May 13 12:00 AM
Abbey DonaldDirectorMay 13 '26Option Exercise0.002,50806,004May 13 12:00 AM
Hoffmeister David FDirectorMay 13 '26Option Exercise0.002,50806,004May 13 12:00 AM
Greenberg David C.DirectorMay 13 '26Option Exercise0.002,50809,214May 13 12:00 AM
Hernandez LaurieDirectorMay 13 '26Option Exercise0.002,50804,862May 13 12:00 AM
KENNEDY KOLLEEN TDirectorMay 13 '26Option Exercise0.002,50804,539May 13 12:00 AM
Greenberg David C.DirectorMay 12 '26Option Exercise101.064,848489,93810,384May 13 12:00 AM
Greenberg David C.DirectorMay 12 '26Sale122.912,424297,9347,960May 13 12:00 AM
Jain VivekChairman and CEOMar 15 '26Option Exercise0.0043,9440134,106Mar 16 12:00 AM
Bonnell Brian MichaelChief Financial OfficerMar 15 '26Option Exercise0.0029,296076,097Mar 16 12:00 AM
Voigtlander Christian B.Chief Operating OfficerMar 15 '26Option Exercise0.0029,296051,154Mar 16 12:00 AM
Woolson DanielVP, GM-Infusion CapitalMar 15 '26Option Exercise0.005,848025,897Mar 16 12:00 AM
Sousa BenChief Information OfficerMar 15 '26Option Exercise0.002,60006,044Mar 16 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR